Antigen delivery systems ii. development of live recombinant attenuated bacterial antigen and dna vaccine delivery vector vaccines

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 1009-1037

  Curtiss, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882870003     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50060-7     Document Type: Chapter

References (330)

1. Adam T. Exploitation of host factors for efficient infection by Shigella. Int. J. Med. Microbiol. 2001, 291:287-298.
2. Adhya S.L., Shapiro J.A. The galactose operon of E. coli K-12. I. Structural and pleiotropic mutations of the operon. Genetics 1969, 62:231-247.
3. Altboum Z., Barry E.M., Losonsky G., Galen J.E., Levine M.M. Attenuated Shigella flexneri 2a .guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection. Infect. Immun. 2001, 69:3150-3158.
4. Altboum Z., Levine M.M., Galen J.E., Barry E.M. Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain. Infect. Immun. 2003, 71:1352-1360.
5. Anderson R., Dougan G., Roberts M. Delivery of the pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response. Vaccine 1996, 14:1384-1390.
6. Anderson R.J., Pasetti M.F., Sztein M.B., Levine M.M., Noriega F.R. .guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin. Vaccine 2000, 18:2193-2202.
7. Andrianopoulos K., Wang L., Reeves P.R. Identification of the fucose synthetase gene in the colanic acid gene cluster of Escherichia coli K-12. J. Bacteriol. 1998, 180:998-1001.
8. Angelakopoulos H., Loock K., Sisul D.M., Jensen E.R., Miller J.F., Hohmann E.L. Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation. Infect. Immun. 2002, 70:3592-3601.
9. Attridge S.R., Davies R., LaBrooy J.T. Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain. Vaccine 1997, 15:155-162.
10. Audia J.P., Webb C.C., Foster J.W. Breaking through the acid barrier: an orchestrated response to proton stress by enteric bacteria. Int. J. Med. Microbiol. 2001, 291:97-106.
11. Bacon G.A., Burrows T.W., Yates M. The effects of biochemical mutation on the virulence of Bacterium typhosum: the virulence of mutants. Br. J. Exp. Pathol. 1950, 37:714-724.
12. Bacon G.A., Burrows T.W., Yates M. The effects of biochemical mutation on the virulence of Bacterium typhosum: the loss of virulence of certain mutants. Br. J. Exp. Pathol. 1951, 32:85-96.
13. Bagley K.C., Shata M.T., Onyabe D.Y., DeVico A.L., Fouts T.R., Lewis G.K., Hone D.M. Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin. Vaccine 2003, 21:3335-3341.
14. Baier W., Masihi N., Huber M., Hoffmann P., Bessler W.G. Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunization. Immunobiology 2000, 201:391-405.
15. Bajaj V., Lucas R.L., Hwang C., Lee C.A. Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol. Microbiol. 1996, 22:703-714.
16. Baker S.J., Daniels C., Morona R. PhoP/Q regulated genes in Salmonella typhi identification of melittin sensitive mutants. Microb. Pathog. 1997, 22:165-179.
17. Bang I.S., Audia J.P., Park Y.K., Foster J.W. Autoinduction of the ompR response regulator by acid shock and control of the Salmonella enterica acid tolerance response. Mol. Microbiol. 2002, 44:1235-1250.
18. Bang I.S., Kim B.H., Foster J.W., Park Y.K. OmpR regulates the stationary-phase acid tolerance response of Salmonella enterica serovar Typhimurium. J. Bacteriol. 2000, 182:2245-2252.
19. Bao J.X., Clements J.D. Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect. Immun. 1991, 59:3841-3845.
20. Barry E.M., Altboum Z., Losonsky G., Levine M.M. Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains. Vaccine 2003, 21:333-340.
21. Barry E.M., Gomez-duarte O., Chatfield S., Rappuoli R., Pizza M., Losonsky G., Galen J., Levine M.M. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908. Infect. Immun. 1996, 64:4172-4181.
22. Barzu S., Fontaine A., Sansonetti P., Phalipon A. Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier. Infect. Immun. 1996, 64:1190-1196.
23. Baumler A.J., Tsolis R.M., Heffron F. The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches. Proc. Natl. Acad. Sci. USA. 1996, 93:279-283.
24. Bearson B.L., Wilson L., Foster J.W. A low pH-inducible, PhoPQ-dependent acid tolerance response protects Salmonella typhimurium against inorganic acid stress. J. Bacteriol. 1998, 180:2409-2417.
25. Benitez J.A., Silva A.J., Finkelstein R.A. Environmental signals controlling production of hemagglutinin/protease in Vibrio cholerae. Infect. Immun. 2001, 69:6549-6553.
26. Benjamin W.H., Hall P., Briles D.E. A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium. Microb. Pathog. 1991, 11:289-295.
27. Berks B.C. A common export pathway for proteins binding complex redox cofactors?. Mol. Microbiol. 1996, 22:393-404.
28. Bierne H., Mazmanian S.K., Trost M., Pucciarelli M.G., Liu G., Dehoux P., Jansch L., Garcia-del Portillo F., Schneewind O., Cossart P. Inactivation of the srtA gene in Listeria monocytogenes inhibits anchoring of surface proteins and affects virulence. Mol. Microbiol. 2002, 43:869-881. The European Listeria Genome Consortium.
29. Bollen W.S., Gunn B., Lay M., Curtiss R. Colonization of the brain following intranasal inoculation with Salmonella [E-086]. Washington, DC: American Society for Microbiology, 103rd General Meeting 2003, 265.
30. Botsford J.L., Harman J.G. Cyclic AMP in prokaryotes. Microbiol. Rev. 1992, 56:100-122.
31. Brundage R.A., Smith G.A., Camilli A., Theriot J.A., Portnoy D.A. Expression and phosphorylation of the Listeria monocytogenes ActA protein in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:11890-11894.
32. Buchmeier N.A., Lipps C.J., So M.Y., Heffron F. Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Mol. Microbiol. 1993, 7:933-936.
33. Bullifent H.L., Griffin K.F., Jones S.M., Yates A., Harrington L., Titball R.W. Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters. Vaccine 2000, 18:2668-2676.
34. Bumann D., Hueck C., Aebischer T., Meyer T.F. Recombinant live Salmonella spp. for human vaccination against heterologous pathogens. FEMS Immunol. Med. Microbiol. 2000, 27:357-364.
35. Butterton J.R., Beattie D.T., Gardel C.L., Carroll P.A., Hyman T., Killeen K.P., Mekalanos J.J., Calderwood S.B. Heterologous antigen expression in Vibrio cholerae vector strains. Infect. Immun. 1995, 63:2689-2696.
36. Butterton J.R., Ryan E.T., Acheson D.W., Calderwood S.B. Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect. Immun. 1997, 65:2127-2135.
37. Caya F., Fairbrother J.M., Lessard L., Quessy S. Characterization of the risk to human health of pathogenic Escherichia coli isolates from chicken carcasses. J. Food Prot. 1999, 62:741-746.
38. Chabalgoity J.A., Harrison J.A., Esteves A., Demarco de Hormaeche R., Ehrlich R., Khan C.M., Hormaeche C.E. Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains. Infect. Immun. 1997, 65:2402-2412.
39. Charbit A., Newton S.M., Klebba P.E., Clement J.M., Fayolle C., Lo-Man R., Leclerc C., Hofnung M. Expression and immune response to foreign epitopes in bacteria. Perspectives for live vaccine development. Behring Inst. Mitt. 1997, 98:135-142.
40. Charles S., Trigo E., Settje T., Abraham A., Johnson P. Evaluation of a .cya .(crp-cdt) Salmonella choleraesuis commercial vaccine to protect against clinical signs caused by and reduced shedding of Salmonella typhimurium in pigs. Proceedings of the 3rd International Symposium on the Epidemiology and Control of Salmonella in Pork 1999, 293-295. Iowa State University, Extended and Continuing Education. P.B. Bahnson (Ed.).
41. Charles S.D., Abraham A.S., Trigo E.T., Jones G.F., Settje B.A. Reduced shedding and clinical signs of Salmonella typhimurium in nursery pigs vaccinated with a Salmonella choleraesuis vaccine. Swine Health and Production 2000, 8:107-112.
42. Chatfield S., Charles I.G., Makoff A.J., Oxer M.D., Dougan G., Pickard D., Slater D., Fairweather N.F. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine. Biotechnology 1992, 10:888-892.
43. Chatfield S.N., Strahan K., Pickard D., Charles I.G., Hormaeche C.E., Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathog. 1992, 12:145-151.
44. Chen H., Schifferli D.M. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar Typhimurium vaccine strains. Infect. Immun. 2000, 68:3129-3139.
45. Chen H., Schifferli D.M. Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector. Vaccine 2001, 19:3009-3018.
46. Cochlovius B., Stassar M.J., Schreurs M.W., Benner A., Adema G.J. Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity. Immunol. Lett. 2002, 80:89-96.
47. Collins L.V., Attridge S., Hackett J. Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice. Infect. Immun. 1991, 59:1079-1085.
48. Corthesy-Theulaz I.E., Hopkins S., Bachmann D., Saldinger P.F., Porta N., Haas R., Zheng-Xin Y., Meyer T., Bouzourene H., Blum A.L., Kraehenbuhl J.P. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoP expressing urease A and B subunits. Infect. Immun. 1998, 66:581-586.
49. Coster T.S., Hoge C.W., VanDeVerg L.L., Hartman A.B., Oaks E.V., Venkatesan M.M., Cohen D., Robin G., Fontaine-Thompson A., Sansonetti P.J., Hale T.L. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect. Immun. 1999, 67:3437-3443.
50. Cote-Sierra J., Bredan A., Toldos C.M., Stijlemans B., Brys L., Cornelis P., Segovia M., de Baetselier P., Revets H. Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major. Infect. Immun. 2002, 70:240-248.
51. sS) regulon. Mol. Microbiol. 1996, 22:149-160.
52. Curtiss R. Attenuated Salmonella strains as live vectors for the expression of foreign antigens. New Generation Vaccines 1990, 161-188. Marcel Dekker, New York. G.C. Woodrow, M.M. Levine (Eds.).
53. Curtiss R. Vaccines and vaccine technology to prevent typhoid and Salmonella diarrheal diseases. Typhoid Fever and other Salmonellosis. Proceedings of the 4th International Symposium 2001, 1-24. Jeou-Chou Book Co., Taipei, Taiwan, ROC.
54. Curtiss R. Perspective: Bacterial infectious disease control by vaccine development. J. Clin. Invest. 2002, 110:1061-1066.
55. Curtiss R., Doggett T., Nayak A., Srinivasan J. Strategies for the use of live recombinant avirulent bacterial vaccines for mucosal immunization. Essentials of Mucosal Immunology 1996, 499-511. Academic Press, San Diego. H. Kiyono, M.F. Kagnoff (Eds.).
56. Curtiss R., Kelly S.M. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 1987, 55:3035-3043.
57. Curtiss R., MacLeod D.L., Lockman H.A., Galan J.E., Kelly S.M., Mahairas G.G. Colonization and invasion of the intestinal tract by Salmonella. Biology of Salmonella 1993, 191-198. Plenum Press, New York. F. Cabello (Ed.).
58. d'Hauteville H., Sansonetti P.J. Phosphorylation of IcsA by cAMP-dependent protein kinase and its effect on intracellular spread of Shigella flexneri. Mol. Microbiol. 1992, 6:833-841.
59. Daigle F., Hou J.Y., Clark-Curtiss J.E. Microbial gene expression elucidated by selective capture of transcribed sequences (SCOTS). Meth. Enz. 2002, 358:108-122.
60. Dalla Pozza T., Yan H., Meek D., Guzman C.A., Walker M.J. Construction and characterisation of Salmonella typhimurium aroA simultaneously expressing the five pertussis toxin subunits. Vaccine 1998, 16:522-529.
61. Denis F., Badiane S., Chiron J.P., Sow A., Mar I.D. Salmonella meningitis in infants. Lancet 1977, 1:910.
62. Dietrich G., Spreng S., Gentschev I., Goebel W. Bacterial systems for the delivery of eukaryotic antigen expression vectors. Antisense Nucleic Acid Drug Dev. 2000, 10:391-399.
63. Dilts D.A., Riesenfeld-Orn I., Fulginiti J.P., Ekwall E., Granert C., Nonenmacher J., Brey R.N., Cryz S.J., Karlsson K., Bergman K., Thompson T., Hu B., Bruckner A.H., Lindberg A.A. Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity. Vaccine 2000, 18:1473-1484.
64. DiPetrillo M.D., Tibbetts T., Kleanthous H., Killeen K.P., Hohmann E.L. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine 2000, 18:449-459.
65. Doggett T., Brown P.K. Attenuated Salmonella as vectors for oral immunization. Mucosal Vaccines 1996, 105-118. Academic Press, San Diego. H. Kiyono, P.L. Ogra, J.R. McGhee (Eds.).
66. Domann E., Wehland J., Rohde M., Pistor S., Hartl M., Goebel W., Leimeister-Wachter M., Wuenscher M., Chakraborty T. A novel bacterial virulence gene in Listeria monocytogenes required for host cell microfilament interaction with homology to the proline-rich region of vinculin. EMBO J. 1992, 11:1981-1990.
67. Dorman C.J., Chatfield S., Higgins C.F., Hayward C., Dougan G. Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo. Infect. Immun. 1989, 57:2136-2140.
68. Dozois C.M., Dho-Moulin M., Bree A., Fairbrother J.M., Desautels C., Curtiss R. Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the Tsh genetic region. Infect. Immun. 2000, 68:4145-4154.
69. Drabner B., Guzman C.A. Elicitation of predictable immune responses by using live bacterial vectors. Biomolecular Engineering 2001, 17:75-82.
70. Dramsi S., Levi S., Triller A., Cossart P. Entry of Listeria monocytogenes into neurons occurs by cell-to-cell spread: an in vitro study. Infect. Immun. 1998, 66:4461-4468.
71. Duncan M.J. Genomics of oral bacteria. Crit. Rev. Oral Biol. Med. 2003, 14:175-187.
72. Dunstan S.J., Ramsay A.J., Strugnell R.A. Studies of immunity and bacterial invasiveness in mice given a recombinant Salmonella vector encoding murine interleukin-6. Infect. Immun. 1996, 64:2730-2736.
73. Dunstan S.J., Simmons C.P., Strugnell R.A. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against heterologous antigen. Infect. Immun. 1998, 66:732-740.
74. DuPont H.L., Levine M.M., Hornick R.B., Formal S.B. Inoculum size in shigellosis and implications for expected mode of transmission. J. Infect. Dis. 1989, 159:1126-1128.
75. Dussurget O., Cabanes D., Dehoux P., Lecuit M., The European Listeria Genome Consortium, Buchrieser C., Glaser P., Cossart P. Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis. Mol. Micobiol. 2002, 45:1095-1106.
76. Dutta P.R., Cappello R., Navarro-Garcia F., Nataro J.P. Functional comparison of serine protease autotransporters of Enterobacteriaceae. Infect. Immun. 2002, 70:7105-7113.
77. Emory S.A., Bouvet P., Belasco J.G. A 5'-terminal stemloop structure can stabilize mRNA in Escherichia coli. Genes Dev. 1992, 6:135-148.
78. Eriksson S., Lucchini S., Thompson A., Rhen M., Hinton J.C. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol. Microbiol. 2003, 47:103-118.
79. Ernst R.K., Dombroski D.M., Merrick J.M. Anaerobiosis, type 1 fimbriae, and growth phase are factors that affect invasion of HEp-2 cells by Salmonella typhimurium. Infect. Immun. 1990, 58:2014-2016.
80. Evans D.T., Chen L.M., Gillis J., Lin K.C., Harty B., Mazzara G.P., Donis R.O., Mansfield K.G., Lifson J.D., Desrosiers R.C., Galan J.E., Johnson R.P. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J. Virol. 2003, 77:2400-2409.
81. Everest P., Allen J., Papakonstantinopoulou A., Mastroeni P., Roberts M., Dougan G. Salmonella typhimurium infections in mice deficient in interleukin-4 production: role of IL-4 in infection-associated pathology. J. Immunol. 1997, 159:1820-1827.
82. Fang F.C., Libby S.J., Buchmeier N.A., Loewen P.C., Switala J., Harwood J., Guiney D.G. The alternative sigma factor katF (rpoS) regulates Salmonella virulence. Proc. Natl. Acad. Sci. USA 1992, 89:11978-11982.
83. Fasano A., Baudry B., Pumplin D.W., Wasserman S.S., Tall B.D., Ketley J.M., Kaper J.B. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc. Natl. Acad. Sci. USA 1991, 88:5242-5246.
84. Feng X., Oropeza R., Kenney L.J. Dual regulation by phospho-OmpR of ssrA/B gene expression in Salmonella pathogenicity island 2. Mol. Microbiol. 2003, 48:1131-1143.
85. Fennelly G.J., Khan S.A., Abadi M.A., Wild T.F., Bloom B.R. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J. Immunol. 1999, 162:1603-1610.
86. Fields P.I., Groisman E.A., Heffron F. A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science 1989, 243:1059-1062.
87. Fields P.I., Swanson R.V., Haidaris C.G., Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. USA. 1986, 83:5189-5193.
88. Finlay B.B., Falkow S. Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. J. Infect. Dis. 1990, 162:1096-1106.
89. Flo J., Tisminetzky S., Baralle F. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent herpes simplex virus-2 induced disease in mice. Vaccine 2001, 19:1772-1782.
90. Fontana M.R., Monaci E., Yanqing L., Guoming Q., Duan G., Rappuoli R., Pizza M. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine 2000, 19:75-85.
91. Foster J.W., Spector M.P. How Salmonella survive against the odds. Annu. Rev. Microbiol. 1995, 49:145-174.
92. Frey S.E., Bollen W., Sizemore D., Campbell M., Curtiss R. Bacteremia associated with live attenuated x8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers. Clin. Immunol. 2001, 101:32-37.
93. Fukasawa T., Nikaido H. Galactose mutants of Salmonella typhimurium. Genetics 1961, 46:1295-1303.
94. Gahan C.G.M., Collins J.K. Vaccination of mice with attenuated mutants of Listeria monocytogenes: requirement for induction of macrophage Ia expression. Microb. Path. 1995, 18:417-422.
95. Gaillard J.L., Berche P., Mounier J., Richard S., Sansonetti P. In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect. Immun. 1987, 55:2822-2829.
96. Galan J.E., Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999, 284:1322-1328.
97. Galan J.E., Curtiss R. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb. Pathog. 1989, 6:433-443.
98. Galan J.E., Curtiss R. Expression of Salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling. Infect. Immun. 1990, 58:1879-1885.
99. Galan J.E., Nakayama K., Curtiss R. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 1990, 94:29-35.
100. Galen J.E., Gomez-Duarte O.G., Losonsky G.A., Halpern J.L., Lauderbaugh C.S., Kaintuck S., Reymann M.K., Levine M.M. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody response to expressed foreign antigens. Vaccine 1997, 15:700-708.
101. Galen J.E., Levine M.M. Can a 'flawless' live vector vaccine strain be engineered?. Trends Microbiol. 2001, 9:372-376.
102. Galen J.E., Nair J., Wang J.Y., Wasserman S.S., Tanner M.K., Sztein M.B., Levine M.M. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect. Immun. 1999, 67:6424-6433.
103. Garcia-del Portillo F., Foster J.W., Finlay B.B. Role of acid tolerance response genes in Salmonella typhimurium virulence. Infect. Immun. 1993, 61:4489-4492.
104. + as an extracellular signal: environmental regulation of Salmonella virulence. Cell 1996, 84:165-174.
105. Garmory H.S., Griffin K.F., Brown K.A., Titball R.W. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine 2003, 21:3051-3057.
106. Gentschev I., Dietrich G., Spreng S., Kolb-Maurer A., Daniels J., Hess J., Kaufmann S.H., Goebel W. Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes. J. Biotechnol. 2000, 83:19-26.
107. Gerdes K., Gultyaev A.P., Franch T., Pedersen K., Mikkelsen N.D. Antisense RNA-regulated programmed cell death. Annu. Rev. Genet. 1997, 31:1-31.
108. Germanier R., Furer E. Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of galE mutants of Salmonella typhimurium. Infect. Immun. 1971, 4:663-673.
109. Germanier R., Furer E. Isolation and characterization of GalE mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 1975, 131:553-558.
110. Giannella R.A., Washington O., Gemski P., Formal S.B. Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella. J. Infect. Dis. 1973, 128:69-75.
111. Gibson K.J., Blaha T., Frank R.K., Charles S.D., Trigo E. Investigation into the capability of a Salmonella choleraesuis live vaccine to reduce the shedding of Salmonella tyhimurium in swine. Proceedings of the 3rd International Symposium on the Epidemiology and Control of Salmonella in Pork 1999, 302-304. Iowa State University, Extended and Continuing Education. P.B. Bahnson (Ed.).
112. Goldberg M.B. Actin-based motility of intracellular microbial pathogens. Microbiol. Mol. Biol. Rev. 2001, 65:595-626.
113. Gomez-Duarte O.G., Lucas B., Yan Z.X., Panthel K., Haas R., Meyer T.F. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 1998, 16:460-471.
114. Gonzalez C.R., Noriega F.R., Huerta S., Santiago A., Vega M., Paniagua J., Ortiz-Navarrete V., Isibasi A., Levine M.M. Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana. Vaccine 1998, 16:1043-1052.
115. Graham J.E., Clark-Curtiss J.E. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc. Natl. Acad. Sci. USA. 1999, 96:11554-11559.
116. Grillot-Courvalin C., Goussard S., Huetz F., Ojcius D.M., Courvalin P. Functional gene transfer from intracellular bacteria to mammalian cells. Nat. Biotechnol. 1998, 16:862-866.
117. Groisman E.A., Chiao E., Lipps C.J., Heffron F. Salmonella typhimurium phoP virulence gene is a transcriptional regulator. Proc. Natl. Acad. Sci. USA. 1989, 86:7077-7081.
118. Guillobel H.C., Carinhanha J.I., Cardenas L., Clements J.D., de Almeida D.F., Ferreira L.C. Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin in systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain. Infect. Immun. 2000, 68:4349-4353.
119. Gulig P.A., Curtiss R. Plasmid-associated virulence of Salmonella typhimurium. Infect. Immun. 1987, 55:2891-2901.
120. Gunn J.S. Mechanisms of bacterial resistance and response to bile. Microbes Infect. 2000, 2:907-913.
121. Gunn J.S., Ernst R.K., McCoy A.J., Miller S.I. Constitutive mutations of the Salmonella enterica serovar Typhimurium transcriptional virulence regulator phoP. Infect. Immun. 2000, 68:3758-3762.
122. Hackett J., Kotlarski I., Mathan V., Francki K., Rowley D. The colonization of Peyer's patches by a strain of Salmonella typhimurium cured of the cryptic plasmid. J. Infect. Dis. 1986, 153:1119-1125.
123. Hall H.K., Foster J.W. The role of fur in the acid tolerance response of Salmonella typhimurium is physiologically and genetically separable from its role in iron acquisition. J. Bacteriol. 1996, 178:5683-5691.
124. Hantman M.J., Hohmann E.L., Murphy C.G., Knipe D.M., Miller S.I. Antigen delivery systems: development of recombinant live vaccines using viral or bacterial vectors. Mucosal Immunology 1999, 779-791. Academic Press, San Diego. P.L. Ogra, M.E. Lamm, J. Bienenstock, J. Mestecky, W. Strober, J.R. McGhee (Eds.).
125. Heithoff D.M., Sinsheimer R.L., Low D.A., Mahan M.J. An essential role for DNA adenine methylation in bacterial virulence. Science 1999, 284:967-970.
126. Hensel M., Shea J.E., Gleeson C., Jones M.D., Dalton E., Holden D.W. Simultaneous identification of bacterial virulence genes by negative selection. Science 1995, 269:400-403.
127. Hess J., Gentschev I., Miko D., Welzel M., Ladel C., Goebel W., Kaufmann S.H. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA. 1996, 93:1458-1463.
128. Hess J., Grode L., Gentschev I., Fensterle J., Dietrich G., Goebel W., Kaufmann S.H. Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination. Microbes Infect. 2000, 2:1799-1806.
129. Hess J., Grode L., Hellwig J., Contradt P., Gentschev I., Goebel W., Ladel C., Kaufmann S.H. Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG. FEMS Immunol. Med. Microbiol. 2000, 27:283-289.
130. Hohmann E.L., Oletta C.A., Killeen K.P., Miller S.I. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis. 1996, 173:1408-1414.
131. Hohmann E.L., Oletta C.A., Loomis W.P., Miller S.I. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. USA. 1995, 92:2904-2908.
132. Hohmann E.L., Oletta C.A., Miller S.I. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 1996, 14:19-24.
133. Hoiseth S.K., Stocker B.A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981, 291:238-239.
134. Hondalus M.K., Bardarov S., Russell R., Chan J., Jacobs W.R., Bloom B.R. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 2000, 68:2888-2889.
135. Hone D., Attridge S., van den Bosch L., Hackett J. A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microb. Pathog. 1988, 5:407-418.
136. Hone D.M., Attridge S.R., Forrest B., Morona R., Daniels D., LaBrooy J.T., Bartholomeusz R.C., Shearman D.J., Hackett J. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect. Immun. 1988, 56:1326-1333.
137. Hone D.M., DeVico A.L., Fouts T.R., Onyabe D.Y., Agwale S.M., Wambebe C.O., Blattner W.A., Gallo R.C., Lewis G.K. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments. J. Hum. Virol. 2002, 5:17-23.
138. Hone D.M., Harris A.M., Chatfield S., Dougan G., Levine M.M. Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 1991, 9:810-816.
139. Hone D.M., Powell J., Crowley R.W., Maneval D., Lewis G.K. Lipopolysaccharide from an Escherichia coli htrB msbB mutant induces high levels of MIP-1 α and MIP-1 β secretion without inducing TNF-α and IL-1 . J. Hum. Virol. 1998, 1:251-256.
140. Hone D.M., Tacket C.O., Harris A.M., Kay B., Losonsky G., Levine M.M. Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J. Clin. Invest. 1992, 90:412-420.
141. Hopkins S., Kraehenbuhl J.P., Schodel F., Potts A., Peterson D., de Grandi P., Nardelli-Haefliger D. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 1995, 63:3279-3286.
142. Hosmalin A., Andrieu M., Loing E., Desoutter J.F., Hanau D., Gras-Masse H., Dautry-Varsat A., Guillet J.G. Lipopeptide presentation pathway in dendritic cells. Immunol. Lett. 2001, 79:97-100.
143. Huang Y., Hajishengallis G., Michalek S.M. Construction and characterization of a Salmonella enterica serovar Typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter. Infect. Immun. 2000, 68:1549-1556.
144. Humphries A.D., Raffatellu M., Winter S., Weening E.H., Kingsley R.A., Droleskey R., Zhang S., Figueiredo J., Khare S., Nunes J., Adams L.G., Tsolis R.M., Baumler A.J. The use of flow cytometry to detect expression of subunits encoded by 11 Salmonella enterica serotype Typhimurium fimbrial operons. Mol. Microbiol. 2003, 48:1357-1376.
145. Jacobs W.R., Snapper S.B., Bloom B.R. Beyond BCG: developing recombinant BCG multivaccine vehicle. Molecular Biology and Infectious Diseases 1988, 207-212. Elsevier, New York. M. Schwartz (Ed.).
146. Janssen R., Tommassen J. PhoE protein as a carrier for for eign epitopes. Int. Rev. Immunol. 1994, 11:113-121.
147. John M., Crean T.I., Calderwood S.B., Ryan E.T. In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. Infect. Immun. 2000, 68:1171-1175.
148. Jonquieres R., Pizarro-Cerda, Cossart P. Synergy between the N- and C-terminal domains of InlB for efficient invasion of non-phagocytic cells by Listeria monocytogenes. Mol. Micobiol. 2001, 42:955-965.
149. Kang H.Y., Curtiss R. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol. Med. Microbiol. 2003, 37:99-104.
150. Kang H.Y., Lee T.H., Zhang X., Curtiss R. Variation of the PspA immune responses induced by live PspA-Salmonella vaccines carrying different types of attenuations and surface adhesions [E-56]. American Society for Microbiology, 102nd General Meeting 2002, 197. American Society for Microbiology, Washington, DC.
151. Kang H.Y., Srinivasan J., Curtiss R. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine. Infect. Immun. 2002, 70:1739-1749.
152. Kaniga K., Compton M.S., Curtiss R., Sundaram P. Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection. Infect. Immun. 1998, 66:5599-5606.
153. Kaper J.B., Lockman H., Baldini M.M., Levine M.M. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature 1984, 308:655-658.
154. Karem K.L., Bowen J., Kuklin N., Rouse B.T. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. J. Gen. Virol. 1997, 78:427-434.
155. Karim M., Islam N. Salmonella meningitis: report of three cases in adults and literature review. Infection 2002, 30:104-108.
156. Kelly S.M., Bosecker B.A., Curtiss R. Characterization and protective properties of attenuated mutants of Salmonella choleraesuis. Infect. Immun. 1992, 60:4881-4890.
157. Kennedy M.J., Yancey R.J., Sanchez M.S., Rzepkowski R.A., Kelly S.M., Curtiss R. Attenuation and immunogenicity of Δcya Δcrp derivatives of Salmonella choleraesuis in pigs. Infect. Immun. 1999, 67:4628-4636.
158. Khan S.A., Stratford R., Wu T., Mckelvie N., Bellaby T., Hindle Z., Sinha K.A., Eltze S., Mastroeni P., Pickard D., Dougan G., Chatfield S., Brennan F.R. Salmonella typhi and S. typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors. Vaccine 2003, 21:538-548.
159. Kier L.D., Weppelman R.M., Ames B.N. Regulation of nonspecific acid phosphatase in Salmonella: phoN and phoP genes. J. Bacteriol. 1979, 138:155-161.
160. Kingsley R.A., van Amsterdam K., Kramer N., Baumler A.J. The shdA gene is restricted to serotypes of Salmonella enterica subspecies I and contributes to efficient and prolonged fecal shedding. Infect. Immun. 2000, 68:2720-2727.
161. Klauser T., Pohlner J., Meyer T.F. Extracellular transport of cholera toxin B subunit using Neisseria IgA protease β-domain: conformation-dependent outer membrane translocation. EMBO J. 1990, 9:1991-1999.
162. Koesling J., Lucas B., Develioglou L., Aebischer T., Meyer T.F. Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy. Vaccine 2001, 20:413-420.
163. Kohler J.J., Pathangey L.B., Brown T.A. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response. Oral Microbiol. Immunol. 1998, 13:81-88.
164. Kohler J.J., Pathangey L.B., Gillespie S.R., Brown T.A. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar Typhimurium expressing a Porphyromonas gingivalis hemagglutinin. Infect. Immun. 2000, 68:3116-3120.
165. Kolenbrander P.E. Oral microbial communities: biofilms, interactions, and genetic systems. Annu. Rev. Microbiol. 2000, 54:413-437.
166. Kong W., Wanda S.Y., Curtiss R. Construction and application of hot-vector systems for DNA vaccine vector delivery [Z-016]. American Society for Microbiology, 103rd General Meeting 2003, 677. American Society for Microbiology, Washington, DC.
167. Kong W., Wanda S.Y., Curtiss R. Regulated bacterial lysis for antigen release [E-031]. American Society for Microbiology, 103rd General Meeting 2003, 255. American Society for Microbiology, Washington, DC.
168. Koprowski H., Levine M.M., Anderson R.J., Losonsky G., Pizza M., Barry E.M. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli. Infect. Immun. 2000, 68:4884-4892.
169. Kotloff K.L., Noriega F.R., Samandari T., Sztein M.B., Losonsky G.A., Nataro J.P., Picking W.D., Barry E.M., Levine M.M. Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect. Immun. 2000, 68:1034-1039.
170. Kotloff K.L., Taylor D.N., Sztein M.B., Wasserman S.S., Losonsky G.A., Nataro J.P., Venkatesan M., Hartman A., Picking W.D., Katz D.E., Campbell J.D., Levine M.M., Hale T.L. Phase I evaluation of virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults. Infect. Immun. 2002, 70:2016-2021.
171. Kozarov E., Miyashita N., Burks J., Cerveny K., Brown T.A., McArthur W.P., Progulske-Fox A. Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar Typhimurium vaccine strain. Infect. Immun. 2000, 68:732-739.
172. Kramer U., Konstantin R., Apfel H., Autenrieth I.B., Lattemann C.T. Autodisplay: Development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains. Infect. Immun. 2003, 71:1944-1952.
173. Lagranderie M., Murray A., Gicquel B., Leclerc C., Gheorghiu M. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine 1993, 11:1283-1290.
174. Lasaro M.O., Alves A.M., Guillobel H.C., Almeida D.F., Ferreira L.C. New vaccine strategies against enterotoxigenic Escherichia coli. II: Enhanced systemic and secreted antibody responses against the CFA/I fimbriae by priming with DNA and boosting with a live recombinant Salmonella vaccine. Braz. J. Med. Biol. Res. 1999, 32:241-246.
175. Leary S.E., Griffin K.F., Garmory H.S., Williamson E.D., Titball R.W. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb. Pathog. 1997, 23:167-179.
176. Lecuit M., Vandormael-Pournin S., Lefort J., Huerre M., Gounon P., Dupuy C., Babinet C., Cossart P. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science 2001, 292:1722-1725.
177. Lee C.A., Falkow S. The ability of Salmonella to enter mammalian cells is affected by bacterial growth state. Proc. Natl. Acad. Sci. USA 1990, 87:4304-4308.
178. Lee I.S., Lin J., Hall H.K., Bearson B.L., Foster J.W. The stationary-phase sigma factor sigma S (RpoS) is required for a sustained acid tolerance response in virulent Salmonella typhimurium. Mol. Micobiol. 1995, 17:155-167.
179. Lee J.J., Sinha K.A., Harrison J.A., de Hormaeche R.D., Riveau G., Pierce R.J., Capron A., Wilson R.A., Khan C.M. Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase. Infect. Immun. 2000, 68:2503-2512.
180. Levine M.M. Immunization against bacterial diseases of the intestine. J. Pediatr. Gastroenterol. Nutr. 2000, 31:336-355.
181. Levine M.M., Ferreccio C., Abrego P., Martin O.S., Ortiz E., Cryz S. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 1999, 17:S22-S27.
182. Liljeqvist S., Stahl S. Production of recombinant subunit vaccines: proteins immunogens, live delivery systems and nucleic acid vaccines. J. Biotech. 1999, 73:1-33.
183. Liou G.G., Jane W.N., Cohen S.N., Lin N.S., Lin-Chao S. RNA degradosomes exist in vivo in Escherichia coli as multicomponent complexes associated with the cytoplasmic membrane via the N-terminal region of ribonuclease E. Proc. Natl. Acad. Sci. USA 2001, 98:63-68.
184. Lockman H.A., Curtiss R. Isolation and characterization of conditional adherent and non-type 1 fimbriated Salmonella typhimurium mutants. Mol. Microbiol. 1992, 6:933-945.
185. Londono L.P., Chatfield S., Tindle R.W., Herd K., Gao X.M., Frazer I., Dougan G. Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine 1996, 14:545-552.
186. Londono-Arcila P., Freeman D., Kleanthous H., O'Dowd A.M., Lewis S., Turner A.K., Rees E.L., Tibbitts T.J., Greenwood J., Monath T.P., Darsley M.J. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect. Immun. 2002, 70:5096-5106.
187. Mahan M.J., Slauch J.M., Mekalanos J.J. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 1993, 259:686-688.
188. Makela P.H., Stocker B.A. How genes determine the structure of the Salmonella lipopolysaccharide. J. Gen. Microbiol. 1969, 57:vi.
189. Mastroeni P., Chabalgoity J.A., Dunstan S.J., Maskell D.J., Dougan G. Salmonella: immune responses and vaccines. Vet. J. 2001, 161:132-164.
190. Matsui H., Suzuki M., Isshiki Y., Kodama C., Eguchi M., Kikuchi Y., Motokawa K., Takaya A., Tomoyasu T., Yamamoto M. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar Typhimurium. Infect. Immun. 2003, 71:30-39.
191. McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P., Courtney L., Porwollik S., Ali J., Dante M., Du F., Hou S., Layman D., Leonard S., Nguyen C., Scott K., Holmes A., Grewal N., Mulvaney E., Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M., Waterston R., Wilson R.K. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 2001, 413:852-856.
192. McFarland W.C., Stocker B.A. Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb. Pathog. 1987, 3:129-141.
193. McLaren R.S., Newbury S.F., Dance G.S., Causton H.C., Higgins C.F. mRNA degradation by processive 3′-5′ exoribonucleases in vitro and the implications for prokaryotic mRNA decay in vivo. J. Mol. Biol. 1991, 221:81-95.
194. McSorley S.J., Xu D., Liew F.Y. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infect. Immun. 1997, 65:171-178.
195. Medina E., Guzman C.A. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 2001, 19:1573-1580.
196. Mielcarek N., Alonso S., Locht C. Nasal vaccination using live bacterial vectors. Advanced Drug Delivery Reviews 2001, 51:55-69.
197. Miller S.I. PhoP/PhoQ: macrophage-specific modulators of Salmonella virulence?. Mol. Microbiol. 1991, 5:2073-2078.
198. Miller S.I., Kukral A.M., Mekalanos J.J. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. USA 1989, 86:5054-5058.
199. Mills S.D., Ruschkowski S.R., Stein M.A., Finlay B.B. Trafficking of porin-deficient Salmonella typhimurium mutants inside HeLa cells: ompR and envZ mutants are defective for the formation of Salmonella-induced filaments. Infect. Immun. 1998, 66:1806-1811.
200. Molin S., Boe L., Jensen L.B., Kristensen C.S., Givskov M., Ramos J.L., Bej A.K. Suicidal genetic elements and their use in biological containment of bacteria. Annu. Rev. Microbiol. 1993, 47:139-166.
201. Mollenkopf H.J., Groine-Triebkorn D., Andersen P., Hess J., Kaufmann S.H. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine 2001, 19:4028-4035.
202. Mounier J., Ryter A., Coquis-Rondon M., Sansonetti P.J. Intracellular and cell-to-cell spread of Listeria monocytogenes involves interaction with F-actin in the enterocytelike cell line Caco-2. Infect. Immun. 1990, 58:1048-1058.
203. + expression-cloning vector: Stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Tech. 1988, 6:693-697.
204. Nardelli-Haefliger D., Benyacoub J., Lemoine R., Hopkins-Donaldson S., Potts A., Hartman F., Kraehenbuhl J.P., De Grandi P. Nasal vaccination with attenuated Salmonella typhimurium strains expressing the hepatitis B nucleocapsid: dose response analysis. Vaccine 2001, 19:2854-2861.
205. Nardelli-Haefliger D., Kraehenbuhl J.P., Curtiss R., Schodel F., Potts A., Kelly S., De Grandi P. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect. Immun. 1996, 64:5219-5224.
206. Nardelli-Haefliger D., Roden R.B., Benyacoub J., Sahli R., Kraehenbuhl J.P., Schiller J.T., Lachat P., Potts A., De Grandi P. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 1997, 65:3328-3336.
207. Navis C.J., Nickerson C.A., Wilmes-Riesenberg M.R., Curtiss R. Construction of Salmonella typhimurium strains containing mutations in one or more adhesins and their effect on virulence [B-213]. American Society for Microbiology, 98th General Meeting 1998, 91. American Society for Microbiology, Washington, DC.
208. Nayak A.R., Tinge S.A., Tart R.C., McDaniel L.S., Briles D.E., Curtiss R. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect. Immun. 1998, 66:3744-3751.
209. Newton S.M., Jacob C.O., Stocker B.A. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 1989, 244:70-72.
210. Nickerson C.A., Curtiss R. Role of sigma factor RpoS in initial stages of Salmonella typhimurium infection. Infect. Immun. 1997, 65:1814-1823.
211. Noriega F.R., Losonsky G., Lauderbaugh C., Liao F.M., Wang J.Y., Levine M.M. Engineered aguaB-A virG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine. Infect. Immun. 1996, 64:3055-3061.
212. Noriega F.R., Losonsky G., Wang J.Y., Formal S.B., Levine M.M. Further characterization of aroA virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. Infect. Immun. 1996, 64:23-27.
213. Noriega F.R., Wang J.Y., Losonsky G., Maneval D.R., Hone D.M., Levine M.M. Construction and characterization of attenuated aroA viG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect. Immun. 1994, 62:5168-5172.
214. O'Hara E.B., Chekanova J.A., Ingle C.A., Kushner Z.R., Peters E., Kushner S.R. Polyadenylylation helps regulate mRNA decay in Escherichia coli. Proc. Natl Acad Sci USA 1995, 92:1807-1811.
215. Ochsner U.A., Snyder A., Vasil A.I., Vasil M.L. Effects of the twin-arginine translocase on secretion of virulence factors, stress response, and pathogenesis. Proc. Natl. Acad. Sci. USA 2002, 99:8312-8317.
216. Oggioni M.R., Medaglini D., Maggi T., Pozzi G. Engineering the gram-positive cell surface for construction of bacterial vaccine vectors. Methods 1999, 19:163-173.
217. Ohara N., Yamada T. Recombinant BCG vaccines. Vaccine 2001, 19:4089-4098.
218. Orr N., Galen J.E., Levine M.M. Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA. Infect. Immun. 1999, 67:4290-4294.
219. Orr N., Galen J.E., Levine M.M. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVC 908-htrA. Vaccine 2001, 19:1694-1700.
220. Paglia P., Aroli I., Frahm N., Chakraborty T., Colombo M.P., Guzman C.A. The defined attenuated Listeria monocytogenes mpl2 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma. Eur. J. Immunol. 1997, 27:1570-1576.
221. Palmer T., Berks B.C. Moving folded proteins across the bacterial cell membrane. Microbiology 2003, 149:547-556.
222. Pardon P., Popoff M.Y., Coynault C., Marly J., Miras I. Virulence-associated plasmids of Salmonella serotype Typhimurium in experimental murine infection. Ann. Inst. Pasteur Microbiol. 1986, 137B:47-60.
223. Pascual D.W., Hone D.M., Hall S., van Ginkel F.W., Yamamoto M., Walters N., Fujihashi K., Powell R.J., Wu S., Van Cott J.L., Kiyono H., McGhee J.R. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect. Immun. 1999, 67:6249-6256.
224. Pasetti M.F., Anderson R.J., Noriega F.R., Levine M.M., Sztein M.B. Attenuated guaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clin Immunol 1999, 92:76-89.
225. Pasetti M.F., Pickett T.E., Levine M.M., Sztein M.B. A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model. Vaccine 2000, 18:3208-3213.
226. Pavelka M.S., Chen B., Kelley C.L., Collins F.M., Jacobs W.R. Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 2003, 71:4190-4192.
227. Pawelec D., Rozynek E., Popowski J., Jagusztyn-Krynicka E.K. Cloning and characterization of a Campylobacter jejuni 72Dz/92 gene encoding a 30 kDa immunopositive protein, component of the ABC transport system; expression of the gene in avirulent Salmonella typhimurium. FEMS Immunol. Med. Microbiol. 1997, 19:137-150.
228. Pereira C.M., Guth B.E., Sbrogio-Almeida M.E., Castilho B.A. Antibody response against Escherichia coli heat-stable enterotoxin expressed as fusions to flagellin. Microbiology 2001, 147:861-867.
229. Peters C., Paterson Y. Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts. Vaccine 2003, 21:1187-1194.
230. Pickett T.E., Pasetti M.F., Galen J.E., Sztein M.B., Levine M.M. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors. Infect. Immun. 2000, 68:205-213.
231. Pizarro-Cerda J., Jonquieres R., Gouin E., Vandekerckhove J., Garin J., Cossart P. Distinct protein patterns associated with Listeria monocytogenes InlA- or InlB-phagosomes. Cell Microbiol. 2002, 4:101-115.
232. Powell C.J., DeSett C.R., Lowenthal J.P., Berman S. The effect of adding iron to mucin on the enhancement of virulence for mice of Salmonella typhi strain TY2. J. Biol. Stand. 1980, 8:79-85.
233. Prouty A.M., Gunn J.S. Salmonella enterica serovar Typhimurium invasion is repressed in the presence of bile. Infect. Immun. 2000, 68:6763-6769.
234. Provence D.L., Curtiss R. Role of crl in avian pathogenic Escherichia coli: a knockout mutation of crl does not affect hemagglutination activity, fibronectin binding, or curli production. Infect. Immun. 1992, 60:4460-4467.
235. Provence D.L., Curtiss R. Isolation and characterization of a gene involved in hemagglutination by an avian pathogenic Escherichia coli strain. Infect. Immun. 1994, 62:1369-1380.
236. Redman T.K., Harmon C.C., Michalek S.M. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A (SpaA) of Streptococcus sobrinus: effects of the Salmonella virulence plasmid on the induction of protective and sustained humoral responses in rats. Vaccine 1996, 14:868-878.
237. Reglier-Poupet H., Pellegrini E., Charbit A., Berche P. Identification of LpeA, a PsaA-like membrane protein that promotes cell entry by Listeria monocytogenes. Infect. Immun. 2003, 71:474-482.
238. Revaz V., Benyacoub J., Kast W.M., Schiller J.T., De Grandi P., Nardelli-Haefliger D. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice. Virology 2001, 279:354-360.
239. Ritz D., Beckwith J. Roles of thiol-redox pathways in bacteria. Annu. Rev. Microbiol. 2001, 55:21-48.
240. Robbe-Saule V., Coynault C., Norel F. The live oral typhoid vaccine Ty21a is a rpoS mutant and is susceptible to various environmental stresses. FEMS Microbiol. Lett. 1995, 126:171-176.
241. Robbe-Saule V., Norel F. The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a. FEMS Microbiol. Lett. 1999, 170:141-143.
242. Roberts M., Bacon A., Li J., Chatfield S. Prior to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection form tetanus toxin in mice immunized with Salmonella strains expressing fragment C. Infect. Immun. 1999, 67:3810-3815.
243. Roberts M., Chatfield S., Pickard D., Li J., Bacon A. Comparison of abilities of Salmonella enterica serovar Typhimurium aroA aroD and aroA htrA mutants to act as live vectors. Infect. Immun. 2000, 68:6041-6043.
244. Roberts M., Chatfield S.N., Dougan G. Salmonella as carriers of heterologous antigens. Novel Delivery Systems for Oral Vaccines 1994, 27-58. CRC Press, Boca Raton, Florida. D.T. O'Hagan (Ed.).
245. Roberts M., Li J., Bacon A., Chatfield S. Oral vaccination against tetanus: Comparison of the immunogenicities of Salmonella strains expressing fragment C form the nirB and htrA promoters. Infect. Immun. 1998, 66:3080-3087.
246. Rogers S., Wells R., Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986, 234:364-368.
247. Roland K., Curtiss R., Sizemore D. Construction and evaluation of a Δcya Δcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 1999, 43:429-441.
248. Rosen S.M., Zeleznick L.D., Fraenkel D., Wiener I.M., Osborn M.J., Horecker B.L. Characterization of the cell wall lipopolysaccharide of a mutant of Salmonella typhimurium lacking phosphomannose isomerase. Biochem. Z. 1965, 342:375-386.
249. Russmann H., Igwe E.I., Sauer J., Hardt W.D., Bubert A., Geginat G. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J. Immunol. 2001, 167:357-365.
250. Russmann H., Shams H., Poblete F., Fu Y., Galan J.E., Donis R.O. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998, 281:565-568.
251. Russmann H., Weissmuller A., Geginat G., Igwe E.I., Roggenkamp A., Bubert A., Goebel W., Hof H., Heesemann J. Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur. J. Immunol. 2000, 30:1375-1384.
252. Ryan E.T., Butterton J.R., Smith R.N., Carroll P.A., Crean T.I., Calderwood S.B. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect. Immun. 1997, 65:2941-2949.
253. Ryan E.T., Butterton J.R., Zhang T., Baker M.A., Stanley S.L., Calderwood S.B. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice. Infect. Immun. 1997, 65:3118-3125.
254. Ryan E.T., Crean T.I., John M., Butterton J.R., Clements J.D., Calderwood S.B. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae. Infect. Immun. 1999, 67:1694-1701.
255. Ryan E.T., Crean T.I., Kochi S.K., John M., Luciano A.A., Killeen K.P., Klose K.E., Calderwood S.B. Development of a glnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae. Infect. Immun. 2000, 68:221-226.
256. Saklani-Jusforgues H., Fontan E., Soussi N., Milon G., Goossens P.L. Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope. Infect. Immun. 2003, 71:1083-1090.
257. Saltzman D.A., Heise C.P., Hasz D.E., Zebede M., Kelly S.M., Curtiss R., Leonard A.S., Anderson P.M. Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent. Cancer Biother. Radiopharm. 1996, 11:145-153.
258. Sambandamurthy V.K., Wang X., Chen B., Russell R.G., Derrick S., Collins F.M., Morris S.L., Jacobs W.R. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat. Med. 2002, 8:1171-1174.
259. Sansonetti P., Egile C. Molecular bases of epithelial cell invasion by Shigella flexneri. Antonie Van Leeuwenhoek 1998, 74:191-197.
260. Schmitt C.K., Ikeda J.S., Darnell S.C., Watson P.R., Bispham J., Wallis T.S., Weinstein D.L., Metcalf E.S., O'Brien A.D. Absence of all components of the flagellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocolitis. Infect. Immun. 2001, 69:5619-5625.
261. Schodel F., Curtiss R. Salmonella as oral vaccine carriers. Dev. Biol. Stand. 1995, 84:245-253.
262. Schodel F., Kelly S., Tinge S., Hopkins S., Peterson D., Milich D., Curtiss R. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization. Adv. Exp. Med. Biol. 1996, 397:15-21.
263. Schriefer A., Maltez J.R., Silva N., Stoeckle M.Y., Barral-Netto M., Riley L.W. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live Salmonella vaccine strain. Vaccine 1999, 17:770-778.
264. Schubert W.D., Urbanke C., Ziehm T., Beier V., Machner M.P., Domann E., Wehland J., Chakraborty T., Heinz D.W. Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin. Cell 2002, 111:825-836.
265. Shata M.T., Hone D.M. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity. J. Virol. 2001, 75:9665-9670.
266. Sirard J.C., Niedergang F., Kraehenbuhl J.P. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol. Rev. 1999, 171:5-26.
267. Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 1995, 270:299-302.
268. Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine 1997, 15:804-807.
269. Spreng S., Gentschev I., Goebel W., Weidinger G., ter Meulen V., Niewiesk S. Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis. Microbes Infect. 2000, 2:1687-1692.
270. Stathopoulos C., Georgiou G., Earhart C.F. Characterization of Escherichia coli expressing an Lpp OmpA(46-159)-PhoA fusion protein localized in the outer membrane. Appl. Microbiol. Biotechnol. 1996, 45:112-119.
271. Steger K.K., Valentine P.J., Heffron F., So M., Pauza C.D. Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques. Vaccine 1999, 17:923-932.
272. Steidler L., Neirynck S., Huyghebaert N., Snoeck V., Vermeire A., Goddeeris B., Cox E., Remon J.P., Remaut E. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 2003, 21:785-789.
273. Stocker B.A. Aromatic-dependent Salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. J. Biotech. 2000, 83:45-50.
274. Stocker B.A., Makela P.H. Genetics of the (gram-negative) bacterial surface. Proc. R. Soc. Lond. B Biol. Sci. 1978, 202:5-30.
275. Stocker B.A., Makela P.H. Genetic determination of bacterial virulence, with special reference to Salmonella. Curr. Top. Microbiol. Immunol. 1986, 124:149-172.
276. Strugnell R.A., Maskell D., Fairweather N., Pickard D., Cockayne A., Penn C., Dougan G. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 1990, 88:57-63.
277. Suarez M., Gonzalez-Zorn B., Vega Y., Chico-Calero I., Vazquez-Boland J.A. A role for ActA in epithelial cell invasion by Listeria monocytogenes. Cell Microbiol. 2001, 3:853-864.
278. Suh J., Wirtz D., Hanes J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl. Acad. Sci. USA 2003, 100:3878-3882.
279. Svensson M., Pfeifer J., Stockinger B., Wick M.J. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells. Behring. Inst. Mitt. 1997, 98:197-211.
280. Sydenham M., Douce G., Bowe F., Ahmed S., Chatfield S., Dougan G. Salmonella enterica serovar Typhimurium surA mutants are attenuated and effective live oral vaccines. Infect. Immun. 2000, 68:1109-1115.
281. Tacket C.O., Galen J., Sztein M.B., Losonsky G., Wyant T.L., Nataro J., Wasserman S.S., Edelman R., Chatfield S., Dougan G., Levine M.M. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin. Immunol. 2000, 97:146-153.
282. Tacket C.O., Hone D.M., Curtiss R., Kelly S.M., Losonsky G., Guers L., Harris A.M., Edelman R., Levine M.M. Comparison of the safety and immunogenicity of aroC aroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infect. Immun. 1992, 60:536-541.
283. Tacket C.O., Hone D.M., Losonsky G., Guers L., Edelman R., Levine M.M. Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine 1992, 10:443-446.
284. Tacket C.O., Kelly S.M., Schodel F., Losonsky G., Nataro J.P., Edelman R., Levine M.M., Curtiss R. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect. Immun. 1997, 65:3381-3385.
285. Tacket C.O., Sztein M.B., Losonsky G.A., Wasserman S.S., Nataro J.P., Edelman R., Pickard D., Dougan G., Chatfield S.N., Levine M.M. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 1997, 65:452-456.
286. Thomas W.D., Wagner S.P., Welch R.A. A heterologous membrane protein domain fused to the C-terminal ATP-binding domain of HlyB can export Escherichia coli hemolysin. J. Bacteriol. 1992, 174:6771-6779.
287. Thompson R.J., Bouwer H.G., Portnoy D.A., Frankel F.R. Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. Infect. Immun. 1998, 66:3552-3561.
288. Tijhaar E.J., Zheng-Xin Y., Karlas J.A., Meyer T.F., Stukart M.J., Osterhaus A.D., Mooi F.R. Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain. Vaccine 1994, 12:1004-1111.
289. Tilney L.G., Portnoy D.A. Actin filaments and growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J. Cell Biol. 1989, 109:1597-1608.
290. Townsend S.M., Kramer N.E., Edwards R., Baker S., Hamlin N., Simmonds M., Stevens K., Maloy S., Parkhill J., Dougan G., Baumler A.J. Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences. Infect. Immun. 2001, 69:2894-2901.
291. Trucksis M., Galen J.E., Michalski J., Fasano A., Kaper J.B. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc. Natl. Acad. Sci. USA 1993, 90:5267-5271.
292. Turner A.K., Terry T.D., Sack D., Londono-Arcila P., Darsley M.J. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect. Immun. 2001, 69:4969-4979.
293. Tzschaschel B.D., Guzman C.A., Timmis K.N., de Lorenzo V. An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium. Nat. Biotechnol. 1996, 14:765-769.
294. Van Cott J.L., Chatfield S.N., Roberts M., Hone D.M., Hohmann E.L., Pascual D.W., Yamamoto M., Kiyono H., McGhee J.R. Regulation of host immune responses by modification of Salmonella virulence genes. Nat. Med. 1998, 4:1247-1252.
295. Van Cott J.L., Staats H.F., Pascual D.W., Roberts M., Chatfield S.N., Yamamoto M., Coste M., Carter P.B., Kiyono H., McGhee J.R. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 1996, 156:1504-1514.
296. van der Velden A.W., Baumler A.J., Tsolis R.M., Heffron F. Multiple fimbrial adhesins are required for full virulence of Salmonella typhimurium in mice. Infect. Immun. 1998, 66:2803-2808.
297. van Velkinburgh J.C., Gunn J.S. PhoP-PhoQ-regulated loci are required for enhanced bile resistance in Salmonella spp. Infect. Immun. 1999, 67:1614-1622.
298. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. USA 1996, 93:12142-12149.
299. Vasquez-Boland J.A., Kocks C., Dramsi S., Ohayon H., Geoffroy C., Mengaud J., Cossart P. Nucleotide sequence of the lecithinase operon of Listeria monocytogenes and possible role of lecithanase in cell-to-cell spread. Infect. Immun. 1992, 60:219-230.
300. Vecino W.H., Morin P.M., Agha R., Jacobs W.R., Fennelly G.J. Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV. Immunol. Lett. 2002, 82:197-204.
301. Vindurampulle C.J., Attridge S.R. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines. Infect. Immun. 2003, 71:287-297.
302. Wang L., Curd H., Reeves P.R. Immunization of mice with live oral vaccine based on a Salmonella enterica (sv Typhimurium) aroA strain expressing the Escherichia coli O111 O antigen. Microb. Pathog. 1999, 27:55-59.
303. Ward S.J., Douce G., Figueiredo D., Dougan G., Wren B.W. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect. Immun. 1999, 67:2145-2152.
304. Warren R.L., Lu D., Sizemore D.R., Baron L.S., Kopecko D.J. Method for identifying microbial antigens that simulate specific lymphocyte responses: application to Salmonella. Proc. Natl. Acad. Sci. USA 1990, 87:9823-9827.
305. Waterman S.R., Small P.L. Identification of sigma S-dependent genes associated with the stationary-phase acid-resistance phenotype of Shigella flexneri. Mol. Micobiol. 1996, 21:925-940.
306. Welch R.A. Pore-forming cytolysins of gram-negative bacteria. Mol. Microbiol. 1991, 5:521-528.
307. Whittle B.L., Verma N.K. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. Vaccine 1997, 15:1737-1740.
308. Wick M.J., Harding C.V., Twesten N.J., Normark S.J., Pfeifer J.D. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol. Microbiol. 1995, 16:465-476.
309. Wiesmuller K.H., Fleckenstein B., Jung G. Peptide vaccines and peptide libraries. Biol. Chem. 2001, 382:571-579.
310. Wilmes-Riesenberg M.R., Bearson B., Foster J.W., Curtiss R. The role of the acid tolerance response in the virulence of Salmonella typhimurium. Infect. Immun. 1996, 64:1085-1092.
311. Woo P.C., Wong L.P., Zheng B.J., Yuen K.Y. Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium. Vaccine 2001, 19:2945-2954.
312. World Bank. Communicable Diseases. http://www.worldbank.org/hnp.
313. Wosten M.M., Groisman E.A. Molecular characterization of the PmrA regulon. J. Biol. Chem. 1999, 274:27185-27190.
314. Wosten M.M., Kox L.F., Chamnongpol S., Soncini F.C., Groisman E.A. A signal transduction system that responds to extracellular iron. Cell 2000, 103:113-125.
315. Wu S., Beier M., Sztein M.B., Galen J., Pickett T., Holder A.A., Gomez-Duarte O.G., Levine M.M. Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C. J. Biotechnol. 2000, 83:125-135.
316. Wu S., Pascual D.W., Lewis G.K., Hone D.M. Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector. AIDS Res. Hum. Retroviruses 1997, 13:1187-1194.
317. Wyszyznska A., Pawelec D.P., Jagusztyn-Krynicka E.K. Immunological characterization of the Campylobacter jejuni 72Dz/92 cjaD gene product and its fusion with B subunit of E. coli LT toxin. Acta Microbiol. Pol. 2002, 51:313-326.
318. Xu B, Zhang Z.S., Li S.Q., Shu D., Huang C.F. Simultaneous expression of CS3 colonization factor antigen and LT-B/ST fusion enterotoxin antigen of enterotoxigenic Escherichia coli by attenuated Salmonella typhimurium. Yi Chuan Xue Bao 2002, 29:370-376.
319. Xu D., McSorley S.J., Tetley L., Chatfield S., Dougan G., Chan W.L., Satoskar A., David J.R., Liew F.Y. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha and IFN-gamma administered orally via attenuated Salmonella typhimurium. J. Immunol. 1998, 160:1285-1289.
320. Xu F., Hong M., Ulmer J.B. Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella. Vaccine 2003, 21:644-648.
321. Yakhchali B., Manning P.A. Epitope analysis of the CS3 fimbrial subunit of human enterotoxigenic Escherichia coli and the construction of novel CS3::ST and CS3::LT-B immunogens. Behring Inst. Mitt. 1997, 98:124-134.
322. Zhang S., Kingsley R.A., Santos R.L., Andrews-Polymenis H., Raffatellu M., Figueiredo J., Nunes J., Tsolis R.M., Adams L.G., Baumler A.J. Molecular pathogenesis of Salmonella enterica serotype typhimurium-induced diarrhea. Infect. Immun. 2003, 71:1-12.
323. Zhang S., Santos R.L., Tsolis R.M., Stender S., Hardt W.D., Baumler A.J., Adams L.G. The Salmonella enterica serotype Typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect. Immun. 2002, 70:3843-3855.
324. Zhang T., Stanley S.L. Expression of the serine rich Entamoeba histolytica protein (SREHP) in the avirulent vaccine strain Salmonella typhi Ty2 .4297 (.cya .crp .asd): safety and immunogenicity in mice. Vaccine 1997, 15:1319-1322.
325. BADfur .pmi mutants are highly attenuated and induced protective immunity in BALB/c mice [Z-29]. American Society for Microbiology, 102nd General Meeting 2002, 512. American Society for Microbiology, Washington, DC.
326. Zhang X., Kelly S.M., Bollen W.S., Curtiss R. Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 .crp and .cdt deletion mutants. Infect. Immun. 1997, 65:5381-5387.
327. + phenotype expressing HBV hybrid core-pre-S protein [E-3]. American Society for Microbiology, 100th General Meeting 1997, 293. American Society for Microbiology, Washington, DC.
328. Zhang-Barber L., Turner A.K., Dougan G., Barrow P.A. Protection of chickens against experimental fowl typhoid using a nuoG mutant of Salmonella serotype Gallinarum. Vaccine 1998, 16:899-903.
329. Zheng B.J., Ng M.H., Chan K.W., Tam S., Woo P.C., Ng S.P., Yuen K.Y. A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice. Eur. J. Immunol. 2002, 32:3294-3304.
330. Zheng M., Bernard D., Schneider T.D., Storz G. OxyR and SoxRS regulation of fur. J. Bacteriol. 1999, 181:4639-4643.